Hohenstatt, Sophia
Ulfert, Christian
Herweh, Christian
Schönenberger, Silvia
Purrucker, Jan C.
Bendszus, Martin
Möhlenbruch, Markus A.
Vollherbst, Dominik F. http://orcid.org/0000-0002-8992-4757
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 9 June 2022
Accepted: 10 August 2022
First Online: 6 September 2022
Conflict of interest
: C. Ulfert received consulting fees from Johnson & Johnson. C. Herweh is consultant for Brainomix. M. Bendszus reports board membership: DSMB Vascular Dynamics; consultancy: Roche, Guerbet, Codman; grants/grants pending: DFG, Hopp Foundation, Novartis, Siemens, Guerbet, Stryker, Covidien; payment for lectures (including service on speakers bureaus): Novartis, Roche, Guerbet, Teva, Bayer, Codman. M.A. Möhlenbruch has received consulting honoraria, speaker honoraria, and travel support outside this work from Balt, Codman, Covidien/Medtronic, MicroVention, Phenox, and Stryker. D.F. Vollherbst has received travel support outside this work from MicroVention and Stryker GmbH & Co. S. Hohenstatt, S. Schönenberger and J.C. Purrucker declare that they have no competing interests.